| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 3,583,500 | 3,468,200 | 3,507,500 | 2,210,100 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,583,500 | 3,468,200 | 3,507,500 | 2,210,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,194,900 | 3,057,800 | 1,722,500 | 3,256,800 | | Non Recurring |
-
|
-
| 1,523,400 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 388,600 | 410,400 | 261,600 | (1,046,700) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (8,800) |
-
| | Earnings Before Interest And Taxes | 388,600 | 410,400 | 252,800 | (1,046,700) | | Interest Expense | 34,700 | 33,700 | 33,900 | 34,200 | | Income Before Tax | 353,900 | 376,700 | 218,900 | (1,080,900) | | Income Tax Expense | 103,800 | 144,200 | 59,600 | (396,700) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 250,100 | 232,500 | 159,300 | (684,200) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 250,100 | 232,500 | 159,300 | (684,200) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $250,100 | $232,500 | $159,300 | ($684,200) |
|
0.17% Nasdaq 0.00%
Income Statement
